Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Annals of Pharmacotherapy
|
July 15, 2005
Capecitabine-warfarin interaction
Laurel M Janney, Nancee V Waterbury
Diabetes Research and Clinical Practice
|
February 11, 2010
Glucose control in patients with type 2 diabetes based on frequency of insulin glargine administration
Audrey K Housel, Robert F Shaw, Nancee V Waterbury
Clinical Rheumatology
|
June 1, 2023
Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis
David T Wood, Nancee V Waterbury, Brian C Lund
Journal of Managed Care & Specialty Pharmacy
|
August 30, 2018
Evaluation of the HealthImpact Diabetes Risk Model in the Veterans Health Administration
Jonathan R Linder, Nancee V Waterbury, Bruce Alexander, et al.
Age and Ageing
|
October 29, 2024
Assessing 1-year sodium-glucose co-transporter-2 inhibitor tolerance in older adults
Stephanie M Schafer, Marcia C Zeithamel, Nancee V Waterbury, et al.
Pharmacotherapy
|
November 22, 2021
Clinical Impact of GLP-1 receptor agonists in veterans receiving basal-bolus insulin
Olivia M Hopton, Nancee V Waterbury, Jason A Egge, et al.
Primary Care Diabetes
|
February 19, 2021
Evaluation of the metformin initiation rate in veterans with newly identified type 2 diabetes
Kelsey J Zenti, Meaghan M Meyer, Nancee V Waterbury, et al.
The American Journal of Managed Care
|
May 5, 2016
Adding glucose-lowering agents delays insulin initiation and prolongs hyperglycemia
Courtney Hugie, Nancee V Waterbury, Bruce Alexander, et al.
Journal of Managed Care Pharmacy : JMCP
|
November 5, 2011
Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide
Rachel A Skoff, Nancee V Waterbury, Robert F Shaw, et al.
Journal of Managed Care Pharmacy : JMCP
|
May 4, 2011
Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes
Scott Martin Vouri, Robert F Shaw, Nancee V Waterbury, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Annals of Pharmacotherapy
|
July 15, 2005
Capecitabine-warfarin interaction
Laurel M Janney, Nancee V Waterbury
Diabetes Research and Clinical Practice
|
February 11, 2010
Glucose control in patients with type 2 diabetes based on frequency of insulin glargine administration
Audrey K Housel, Robert F Shaw, Nancee V Waterbury
Clinical Rheumatology
|
June 1, 2023
Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis
David T Wood, Nancee V Waterbury, Brian C Lund
Journal of Managed Care & Specialty Pharmacy
|
August 30, 2018
Evaluation of the HealthImpact Diabetes Risk Model in the Veterans Health Administration
Jonathan R Linder, Nancee V Waterbury, Bruce Alexander, et al.
Age and Ageing
|
October 29, 2024
Assessing 1-year sodium-glucose co-transporter-2 inhibitor tolerance in older adults
Stephanie M Schafer, Marcia C Zeithamel, Nancee V Waterbury, et al.
Pharmacotherapy
|
November 22, 2021
Clinical Impact of GLP-1 receptor agonists in veterans receiving basal-bolus insulin
Olivia M Hopton, Nancee V Waterbury, Jason A Egge, et al.
Primary Care Diabetes
|
February 19, 2021
Evaluation of the metformin initiation rate in veterans with newly identified type 2 diabetes
Kelsey J Zenti, Meaghan M Meyer, Nancee V Waterbury, et al.
The American Journal of Managed Care
|
May 5, 2016
Adding glucose-lowering agents delays insulin initiation and prolongs hyperglycemia
Courtney Hugie, Nancee V Waterbury, Bruce Alexander, et al.
Journal of Managed Care Pharmacy : JMCP
|
November 5, 2011
Glycemic control and hypoglycemia in Veterans Health Administration patients converted from glyburide to glipizide
Rachel A Skoff, Nancee V Waterbury, Robert F Shaw, et al.
Journal of Managed Care Pharmacy : JMCP
|
May 4, 2011
Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes
Scott Martin Vouri, Robert F Shaw, Nancee V Waterbury, et al.
Page
of 1